| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|
| Period End Date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 |
|---|
| Sales | 1,482.07 | 1,311.12 | 1,661.74 | 2,000.58 | 1,805.16 | 1,229.22 | 1,249.13 | 1,213.99 | 1,054.20 | 942.16 |
| Total Revenues | 1,482.07 | 1,311.12 | 1,661.74 | 2,000.58 | 1,805.16 | 1,229.22 | 1,249.13 | 1,213.99 | 1,054.20 | 942.16 |
| Cost of goods sold | 1,019.64 | 875.26 | 1,003.56 | 1,173.34 | 1,134.80 | 798.09 | 783.32 | 778.71 | 697.43 | 655.24 |
| Gross Profit | 462.44 | 435.86 | 658.18 | 827.24 | 670.36 | 431.12 | 465.81 | 435.28 | 356.78 | 286.92 |
| Impairment of goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of acquisition-related intangible assets | 22.23 | 16.50 | 15.28 | 15.61 | 16.22 | 16.26 | 18.04 | 18.35 | 18.80 | 20.48 |
| Research and development expenses | 162.18 | 134.05 | 134.87 | 126.32 | 119.20 | 94.29 | 88.52 | 86.29 | 77.88 | 69.94 |
| In-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling and general administrative expenses | 241.61 | 233.91 | 257.94 | 280.88 | 257.71 | 185.07 | 181.34 | 176.20 | 167.64 | 158.26 |
| Restructuring charge | 0.39 | 8.59 | 1.58 | -- | -- | -- | -- | 0.21 | 10.14 | -- |
| Impairment of long-lived assets | -- | -- | -- | -- | -- | -- | -- | (0.39) | (2.21) | -- |
| Other operating income (Expenses) | -- | 0.00 | 0.02 | 0.11 | (1.00) | (1.07) | (1.73) | 0.64 | 0.25 | (0.20) |
| Gain (Loss) on Sale of Assets | (0.57) | 7.64 | 2.05 | 3.65 | (0.25) | (0.11) | 24.43 | -- | -- | -- |
| Total Operating Expenses | 426.97 | 385.41 | 407.61 | 419.04 | 394.38 | 296.79 | 265.20 | 280.79 | 276.42 | 248.87 |
| Income from operations | 35.46 | 50.45 | 250.57 | 408.19 | 275.99 | 134.33 | 200.61 | 154.48 | 80.36 | 38.06 |
| Interest expense | 2.78 | 2.33 | 5.70 | 8.32 | 7.49 | 11.66 | 7.89 | 9.90 | 13.45 | 13.26 |
| Impairment of fixed assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Impairment of cost-basis investment | 5.82 | -- | -- | -- | -- | -- | -- | -- | -- | 3.22 |
| Gain (Loss) on disposal of fixed assets | 13.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Unrealized Gain (Loss) on investments | 28.56 | (0.32) | 18.27 | (16.51) | 28.02 | -- | -- | -- | -- | -- |
| Loss on securities carried at fair value | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income (expense), net | 28.30 | 18.30 | 13.34 | 3.67 | 3.14 | 1.07 | 2.19 | 1.98 | 1.48 | 1.36 |
| Other | (0.69) | 2.89 | 6.72 | 6.79 | 17.55 | 6.42 | 7.08 | 7.10 | 2.20 | 2.10 |
| Amortization of debt discount | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Foreign currency loss, net | (12.82) | (6.31) | (5.26) | 2.12 | (2.11) | (9.81) | (3.74) | (3.70) | (8.00) | -- |
| Total other income (expenses) | 48.50 | 12.23 | 27.36 | (12.25) | 39.11 | (13.99) | (2.36) | (4.52) | (17.77) | (13.02) |
| Income before income taxes and noncontrolling interest | 83.96 | 62.68 | 277.93 | 395.94 | 315.10 | 120.34 | 198.25 | 149.96 | 62.59 | 25.04 |
| Current- Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Current: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Current: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income tax (benefit) provision | 14.79 | 11.84 | 47.29 | 56.69 | 78.81 | 21.11 | 44.13 | 44.56 | 62.33 | 6.56 |
| Deferred: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred: Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Liability for unrecognized tax benefits | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Minority interest in joint venture earnings | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income(Loss) before Preferred Dividend & Noncontrolling Interest | 69.17 | 50.84 | 230.65 | 339.26 | 236.29 | 99.23 | 154.12 | 105.41 | 0.27 | 18.48 |
| Less net (income) loss attributable to noncontrolling interest | 3.03 | 6.82 | 3.47 | 7.97 | 7.53 | 1.14 | 0.87 | 1.39 | 2.07 | 2.54 |
| Net income attributable to common stockholders | 66.14 | 44.02 | 227.18 | 331.28 | 228.76 | 98.09 | 153.25 | 104.02 | (1.81) | 15.94 |
| Basic earnings per share attributable to common stockholders | 1.43 | 0.95 | 4.96 | 7.31 | 5.11 | 1.92 | 3.02 | 2.09 | (0.04) | 0.33 |
| Diluted earnings per share attributable to common stockholders | 1.43 | 0.95 | 4.91 | 7.20 | 5.00 | 1.88 | 2.96 | 2.04 | (0.04) | 0.32 |
| Basic number of shares used in computation | 46.34 | 46.21 | 45.80 | 45.33 | 44.77 | 51.00 | 50.79 | 49.84 | 48.82 | 48.60 |
| Diluted number of shares used in computation | 46.41 | 46.41 | 46.31 | 46.04 | 45.78 | 52.13 | 51.86 | 50.94 | 48.82 | 49.79 |